vimarsana.com

Page 25 - நிர்வகிக்கப்பட்டது பராமரிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Triple-S Management Corporation Reports First Quarter 2021 Results

Share this article Share this article SAN JUAN, Puerto Rico, May 6, 2021 /PRNewswire/ Triple-S Management Corporation (NYSE: GTS), a leading healthcare services company in Puerto Rico, today announced its first quarter 2021 results. Roberto Garcia-Rodriguez, President and Chief Executive Officer, commented: We had a solid start to 2021, generating double-digit revenue growth largely due to strong results at Medicaid, aided by continued steady performance at our Life and P&C segments.  We also made progress on our integrated healthcare strategy, preparing for the introduction of team-based, integrated chronic care management programs later this year. While utilization continued to trend toward more normalized levels as expected, we remain confident in our full-year expectations for 2021.

Recklessness and Responsibility

Misinformation by “thought leaders” and their followers is the primary reason. The no longer believe herd immunity is possible. Instead COVID will become woven into the fabric of everyday life, with new variants popping up from time to time, killing the most vulnerable and sickening thousands of us. Lest one think that s not a big deal, recall the most common version of COVID now circulating in the US came from Britain – and this version is 60% more transmissible than the “original” version. More concerning still, future variants may well be more lethal. While there are many factors contributing to the herd immunity problem, the

Assessing health disparities in breast cancer incidence burden in Tennessee: geospatial analysis

Background Tennessee women experience the 12th highest breast cancer mortality in the United States. We examined the geographic differences in breast cancer incidence in Tennessee between Appalachian and non-Appalachian counties from 2005 to 2015. Methods We used ArcGIS 10.7 geospatial analysis and logistic regression on the Tennessee Cancer Registry incidence data for adult women aged ≥ 18 years (N = 59,287) who were diagnosed with breast cancer from 2005 to 2015 to evaluate distribution patterns by Appalachian county designation. The Tennessee Cancer Registry is a population-based, central cancer registry serving the citizens of Tennessee and was established by Tennessee law to collect and monitor cancer incidence. The main outcome was breast cancer stage at diagnosis. Independent variables were age, race, marital status, type of health insurance, and county of residence.

Curtailing Medicaid coverage of accelerated approval therapies threatens patients access

© Istock To improve their COVID-battered fiscal situations, some states are looking to cut Medicaid, which makes up nearly one-third of average state spending and whose enrollment increased by about 15 percent last year.    Specifically, states like Massachusetts and Tennessee are seeking federal approval to curtail Medicaid coverage of prescription drugs that have received accelerated government approval. At its meeting last month, The Medicaid and CHIP Payment and Access Commission (MACPAC) voted to recommend that Medicaid programs demand higher rebate payments from drug manufacturers for these accelerated medications as a condition of maintaining Medicaid coverage. Such reform would allow states to curtail their coverage of these medications, threatening patient access. It s now up to Congress whether to accept this recommendation.

Curtailing Medicaid coverage of accelerated approval therapies threatens patients access

Curtailing Medicaid coverage of accelerated approval therapies threatens patients access Terry Wilcox and Teonna Woolford, opinion contributors © Istock Curtailing Medicaid coverage of accelerated approval therapies threatens patients access To improve their COVID-battered fiscal situations, some states are looking to cut Medicaid, which makes up nearly one-third of average state spending and whose enrollment increased by about 15 percent last year. Specifically, states like Massachusetts and Tennessee are seeking federal approval to curtail Medicaid coverage of prescription drugs that have received accelerated government approval. At its meeting last month, The Medicaid and CHIP Payment and Access Commission (MACPAC) voted to recommend that Medicaid programs demand higher rebate payments from drug manufacturers for these accelerated medications as a condition of maintaining Medicaid coverage. Such reform would allow states to curtail their coverage of th

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.